Pharmacyclics Stock Price (NASDAQ:PCYC)

Add to My Stocks
$261.25 $0 (0%) PCYC stock closing price May 26, 2015 (Closing)
Prev Close* : $261.25
Market Cap:
$20.14B
Day Low: $0
52 Week Low: $82.51
Open: $0
Volume: $0
Day High: $0
52 Week High: $261.68
Dividend:
0.00

Latest Stock Market News

Latest Articles

Pharmacyclics News - From Partners

PCYC Stockcharts

View PCYC PE ratio, PS ratio stocks charts and compare with peers.
PCYC Chart
Note: Compare Pharmacyclics stock price history with the index and industry peers.

Pharmacyclics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

Pharmacyclics Returns

ROE
(return on equity)

Pharmacyclics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PCYC Industry Peers

Company Price Change (%)
Eisai (ESALY)94.980.76 (0.81%)
Forest Laboratories (FRX)990.77 (0.77%)
Abbvie (ABBV)92.681.66 (1.82%)
Gilead Sciences (GILD)74.830.95 (1.29%)
Bristol-myers Squibb (BMY)61.750.95 (1.56%)
Amgen (AMGN)205.11.9 (0.94%)
Novo Nordisk (NVO)47.50.5 (1.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Lannett Co (LCI)5.50.65 (13.4%)
TherapeuticsMD (TXMD)6.750.53 (8.52%)
Akebia Therapeutics (AKBA)8.330.59 (7.62%)
ArQule (ARQL)5.150.3 (6.19%)
Enanta Pharma (ENTA)97.685.59 (6.07%)
CTI BioPharma (CTIC)2.010.1 (5.24%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Achaogen (AKAO)4.310.25 (5.48%)
Flexion Therapeutics (FLXN)18.870.75 (3.82%)
CORREVIO PHARMA (CORV)4.290.1 (2.28%)
Heron Therapeutics (HRTX)33.10.6 (1.78%)
Portola Pharma (PTLA)28.170.46 (1.61%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Pharmacyclics, Inc. Stock News - Partner Headlines

Pharmacyclics Financial Statements

income statement20142013201220112010
Net Sales or Revenues729.72M260.16M57.96M77.9M2.82M
Net Income86.12M67.01M41.92M56.25M-7.49M
Total Operating Expense566.4M158.74M16.66M16.01M10.34M
View Pharmacyclics income statement
balance sheet20142013201220112010
Total Assets1.06B768.75M355.12M247.75M64.21M
Total Liabilities230.94M141.12M92.6M94.16M6.88M
Shareholders Equity829.16M627.62M262.52M153.58M57.32M
View Pharmacyclics balance sheet
cash flow statement20142013201220112010
Net Increase (Decrease) in Assets Liabilities39.47M-30.85M63.55M77.32M-3.02M
Net Cash from (used by) Operating Activities183.76M88.77M86.08M123.9M-13.24M
Increase (Decrease) in Prop Plant And Equipment-13.91M-18.31M-2.97M-1.32M-0.2M
View Pharmacyclics cash flow statement

Pharmacyclics Stock Message Board

Pharmacyclics stock lost 0%, and the last close price as of May 26, 2015 is $261.25 for PCYC stock. Stock price or share price can be used to find the total market value of a company. Pharmacyclics market cap stands at $20.14B as of May 26, 2015. Pharmacyclics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Pharmacyclics is worth a lot, it will most likely be reflected in an inflated Pharmacyclics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 0 PCYC shares were traded yesterday, and Pharmacyclics stock chart shows that the PCYC stock quote hit a day high of $0 and day low of $0. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Pharmacyclics does not pay dividends. To check the historical stock price movement, all time high, and all time low of PCYC, view Pharmacyclics stock price history.